Kristina Lend

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF TRANSLATIONAL AUTOIMMUNITY. 2025;11:100310
Acylcarnitine enrichment as a characteristic of rheumatoid arthritis fibroblast-like synoviocyte metabolic fingerprint.
Vasileiadis GK; Zhang Y; Laudette M; Fatima T; Hultgård Ekwall A-K; Sureshkumar R; van Vollenhoven R; Lampa J; Gudbjornsson B; Haavardsholm EA; Nordström D; Gröndal G; Hørslev-Petersen K; Lend K; Hetland ML; Nurmohamed M; Østergaard M; Uhlig T; Sokka-Isler T; Rudin A; Borén J; Guma M; Maglio C
Journal article: ARTHRITIS RESEARCH & THERAPY. 2025;27(1):177
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort (vol 27, 156, 2025)
Fatima T; Zhang Y; Vasileiadis GK; Rawshani A; van Vollenhoven R; Lampa J; Gudbjornsson B; Haavardsholm EA; Nordstrom D; Grondal G; Horslev-Petersen K; Lend K; Heiberg MS; Hetland ML; Nurmohamed M; Ostergaard M; Uhlig T; Sokka-Isler T; Rudin A; Maglio C
Article: PLOS ONE. 2025;20(8):e0330823
Low Th2 and high PD1⁺ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritis
Sellden T; Andersson K; Gjertsson I; Hultgard Ekwall A-K; Lend K; Lund Hetland M; Ostergaard M; Uhlig T; Schrumpf Heiberg M; Nurmohamed MT; Lampa J; Sokka Isler T; Nordstrom D; Horslev-Petersen K; Gudbjornsson B; Grondal G; van Vollenhoven R; Maglio C; Lundell A-C; Rudin A
Article: ARTHRITIS RESEARCH & THERAPY. 2025;27(1):156
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort
Fatima T; Zhang Y; Vasileiadis GK; Rawshani A; van Vollenhoven R; Lampa J; Gudbjornsson B; Haavardsholm EA; Nordstroem D; Grondal G; Horslev-Petersen K; Lend K; Heiberg MS; Hetland ML; Nurmohamed M; Ostergaard M; Uhlig T; Sokka-Isler T; Rudin A; Maglio C
Article: ACR OPEN RHEUMATOLOGY. 2025;7(7):e70069
Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid Arthritis
Sellden T; Lend K; Lampa J; Hetland ML; Ostergaard M; Uhlig T; Nordstrom D; Horslev-Petersen K; Gudbjornsson B; Grondal G; Gjertsson I; van Vollenhoven R; Maglio C; Andersson K; Ekwall A-KH; Lundell A-C; Rudin A
Article: ANNALS OF THE RHEUMATIC DISEASES. 2025;84(7):1090-1103
Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis
He Y; Sareila O; Johansson L; Agelii ML; Cheng L; Lundquist A; Lonnblom E; Grondal G; Gudbjornsson B; Horslev-Petersen K; Lampa J; Lend K; Hetland ML; Nordstrom D; Nurmohamed M; Rudin A; Uhlig T; Ostergaard M; Gjertsson I; Rantapaa-Dahlqvist S; Holmdahl R
Article: RMD OPEN. 2025;11(2):e005129
Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial
Lend K; Twisk JWR; Kumar N; Dijkshoorn B; Lampa J; Rudin A; Hetland ML; Uhlig T; Nordstroem D; Ostergaard M; Gudbjornsson B; Sokka-Isler T; Grondal G; Horslev-Petersen K; Nurmohamed MT; Frostegard J; van Vollenhoven RF
Article: ANNALS OF THE RHEUMATIC DISEASES. 2025;84(6):937-948
Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/ hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm
Hetland ML; Heiberg MS; Sokka-Isler T; Rudin A; Ostergaard M; Haavardsholm E; Rutanen J; van Vollenhoven R; Grondal G; Ornbjerg LM; Boyesen P; Lampa J; Nurmohamed M; Gudbjornsson B; Uhlig T; Kononoff A; Lend K; Krabbe S; Olsen IC; Sexton J; Horslev-Petersen K
Article: ACR OPEN RHEUMATOLOGY. 2025;7(1):e11742
Circulating Baseline CXCR3⁺Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis
Scheffler JM; Drevinge C; Lindholm C; Gjertsson I; Lend K; Hetland ML; Ostergaard M; Uhlig T; Heiberg MS; Haavardsholm EA; Nurmohamed MT; Lampa J; Sokka-Isler T; Nordstrom D; Horslev-Petersen K; Gudbjornsson B; Grondal G; van Vollenhoven R; Carlsten H; Lorentzon M; Ekwall A-KH; Rudin A; Islander U
Article: ACR OPEN RHEUMATOLOGY. 2025;7(1):e11756
Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid Arthritis
Vasileiadis GK; Zhang Y; Fatima T; van Vollenhoven R; Lampa J; Gudbjornsson B; Haavardsholm EA; Nordstrom D; Grondal G; Horslev-Petersen K; Lend K; Heiberg MS; Hetland ML; Nurmohamed M; Uhlig T; Sokka-Isler T; Rudin A; Maglio C
Article: RMD OPEN. 2024;10(4):e004838
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study
Dijkshoorn B; Hansildaar R; Vedder D; Soutari N; Rudin A; Nordstroem D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm EA; Grondal G; Hetland ML; Heiberg MS; Ostergaard M; Horslev-Petersen K; Lampa J; van Vollenhoven RF; Antovic A; Nurmohamed MT
Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(12):1657-1665
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial
Lend K; Lampa J; Padyukov L; Hetland ML; Heiberg MS; Nordstroem DC; Nurmohamed MT; Rudin A; Ostergaard M; Haavardsholm EA; Horslev-Petersen K; Uhlig T; Sokka-Isler T; Gudbjornsson B; Grondal G; Frazzei G; Christiaans J; Wolbink G; Rispens T; Twisk JWR; van Vollenhoven RF
Article: RMD OPEN. 2024;10(2):e004227
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study
Dubovyk V; Vasileiadis GK; Fatima T; Zhang Y; Kapetanovic MC; Kastbom A; Rizk M; Soederbergh A; Zhao SS; van Vollenhoven RF; Hetland ML; Haavardsholm EA; Nordstrom D; Nurmohamed MT; Gudbjornsson B; Lampa J; Ostergaard M; Heiberg MS; Sokka-Isler T; Grondal G; Lend K; Horslev-Petersen K; Uhlig T; Rudin A; Maglio C
Article: ARTHRITIS RESEARCH & THERAPY. 2024;26(1):61
Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis
Liu J; Idborg H; Korotkova M; Lend K; van Vollenhoven R; Lampa J; Rudin A; Nordstrom D; Gudbjornsson B; Grondal G; Uhlig T; Horslev-Petersen K; Merete HL; Ostergaard M; Nurmohamed M; Jakobsson P-J
Article: ARTHRITIS & RHEUMATOLOGY. 2024;76(3):363-376
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial
Lend K; Koopman FA; Lampa J; Jansen G; Hetland ML; Uhlig T; Nordstroem D; Nurmohamed M; Gudbjornsson B; Rudin A; Ostergaard M; Heiberg MS; Sokka-Isler T; Horslev-Petersen K; Haavardsholm EA; Grondal G; Twisk JWR; van Vollenhoven R
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(10):1286-1295
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Ostergaard M; van Vollenhoven RF; Rudin A; Hetland ML; Heiberg MS; Nordstrom DC; Nurmohamed MT; Gudbjornsson B; Ornbjerg LM; Boyesen P; Lend K; Horslev-Petersen K; Uhlig T; Sokka T; Grondal G; Krabbe S; Lindqvist J; Gjertsson I; Glinatsi D; Kapetanovic MC; Aga A-B; Faustini F; Parmanne P; Lorenzen T; Giovanni C; Back J; Hendricks O; Vedder D; Rannio T; Grenholm E; Ljosa MK; Brodin E; Lindegaard H; Soderbergh A; Rizk M; Kastbom A; Larsson P; Uhrenholt L; Just SA; Stevens DJ; Laurbjerg TB; Bakland G; Olsen IC; Haavardsholm EA; Lampa J
Article: LANCET RHEUMATOLOGY. 2022;4(10):E688-E698
Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial
Lend K; van Vollenhoven RF; Lampa J; Hetland ML; Haavardsholm EA; Nordstrom D; Nurmohamed M; Gudbjornsson B; Rudin A; Ostergaard M; Uhlig T; Grondal G; Horslev-Petersen K; Heiberg MS; Sokka-Isler T; Koopman FA; Twisk JWR; Van der Horst-Bruinsma I
Article: BMJ-BRITISH MEDICAL JOURNAL. 2020;371:m4328
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
Hetland ML; Haavardsholm EA; Rudin A; Nordstrom D; Nurmohamed M; Gudbjornsson B; Lampa J; Horslev-Petersen K; Uhlig T; Grondal G; Ostergaard M; Heiberg MS; Twisk J; Lend K; Krabbe S; Hyldstrup LH; Lindqvist J; Ekwall A-KH; Gron KL; Kapetanovic M; Faustini F; Tuompo R; Lorenzen T; Cagnotto G; Baecklund E; Hendricks O; Vedder D; Sokka-Isler T; Husmark T; Ljosa M-KA; Brodin E; Ellingsen T; Soderbergh A; Rizk M; Olsson AR; Larsson P; Uhrenholt L; Just SA; Stevens DJ; Laurberg TB; Bakland G; Olsen IC; van Vollenhoven R

Alla övriga publikationer

Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2025;84:372-373
METABOLIC ALTERATIONS IN RHEUMATOID ARTHRITIS: INSIGHTS FROM METABOLOMICS ANALYSIS IN JOINT FIBROBLASTS AND SERUM
Vasileiadis GK; Zhang Y; Laudette M; Fatima T; Ekwall AKH; Sureshkumar R; Vollenhoven RFV; Lampa J; Gudbjornsson B; Haavardsholm EA; Nordstrom D; Grondal G; Horslev-Petersen K; Lend K; Hetland ML; Nurmohamed M; Ostergaard M; Uhlig T; Sokka-Isler T; Rudin A; Boren J; Guma M; Maglio C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2025;84
TAPERING AND DISCONTINUATION OF GLUCOCORTICOIDS IN EARLY RHEUMATOID ARTHRITIS:THE RISK OF FLARE
Lend K; Twisk JWR; Koopman F; Rudin A; Hetland ML; Uhlig T; Nordstroem D; Nurmohamed M; Gudbjornsson B; Horslev-Petersen K; Heiberg MS; Sokka-Isler T; Grondal G; Haavardsholm EA; Ostergaard M; Lampa J; van Vollenhoven RF
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2025;84
HAND-DOMINANT JOINT INVOLVEMENT PATTERN ASSOCIATES WITH FAVORABLE, AND POLYARTHRITIS WITH UNFAVORABLE,TREATMENT RESPONSETO BOTH CSDMARDS AND BDAMRDS IN EARLY RHEUMATOID ARTHRITIS: A COMBINED ANALYSIS OF NORD-STAR AND BESTTRIALS
Nagafuchi Y; Maarseveen TD; Lend K; Rudin A; Gudbjornsson B; Nordstrom D; Haavardsholm EA; Grondal G; Lampa J; Horslev-Petersen K; Heiberg MS; Hetland ML; Nurmohamed M; Ostergaard M; van Vollenhoven RF; Uhlig T; Sokka-Isler T; van den Akker EB; Huizinga T; Bergstra SA; Knevel R
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2024;76:978-981
Biomarkers for Disease Activity and Response to Treatment in Early Rheumatoid Arthritis: Metabolomics and Machine Learning Analyses in NORD-STAR Cohort
Fatima T; Zhang Y; Vasileiadis G; Rawshani A; Van Vollenhoven R; Lampa J; Gudbjornsson B; Haavardsholm E; Nordstrom D; Grondal G; Horslev-Petersen K; Lend K; Heiberg M; Hetland M; Nurmohamed M; Ostergaard M; Uhlig T; Sokka-Isler T; Rudin A; Maglio C
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2024;76:941-943
Plasma Calprotectin Assessed in Multiple Biological Treatment Strategies for Early Rheumatoid Arthritis over 48 Weeks
Stevens D; Sundbakk L; Kazemi A; Heiberg M; Sokka-Isler T; Gudbjornsson B; Lend K; Rudin A; Nurmohamed M; Lampa J; Hetland M; Ostergaard M; Van Vollenhoven R; Uhlig T; Haavardsholm E; Hammer H
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2024;83:839-840
ULTRASOUND REMISSION RATES AFTER 1 YEAR ARE HIGH IN EARLY RA PATIENTS ON INDUCTION TREATMENT: RESULTS FROM THE RANDOMIZED NORD-STAR TRIAL
Heiberg MS; Kisten Y; Kazemi A; Rezaei H; Af Klint E; Ljosa MKA; Brodin E; Stevens D; Bakland G; Karoliussen LF; Bolton-King P; Lindqvist J; Lend K; Lampa J; Uhlig T; Hetland ML; Rudin A; Nordstrom D; Gudbjornsson D; Gudbjornsson B; Nurmohamed MT; Ostergaard M; Grondal G; Sokka-Isler T; Hammer HB; Van Vollenhoven RF; Haavardsholm E
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2024;83:739-740
SERUM METABOLOMICS PROFILING IDENTIFIES POTENTIAL BIOMARKERS FOR DISEASE ACTIVITY AND RESPONSETO TREATMENT IN EARLY RHEUMATOID ARTHRITIS- A NORD-STAR SPIN-OFF STUDY
Fatima T; Vasileiadis GK; Van Vollenhoven RF; Lampa J; Gudbjornsson B; Haavardsholm EA; Nordstrom D; Grondal G; Horslev-Petersen K; Lend K; Heiberg MS; Hetland ML; Nurmohamed M; Ostergaard M; Uhlig T; Sokka-Isler T; Rudin A; Zhang Y; Maglio C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2024;83:85-86
RHEUMATOID FACTOR, ANTI-CITRULLINATED PEPTIDE ANTIBODIES, AND SHARED EPITOPE AS PREDICTORS OF CLINICAL RESPONSE TO TREATMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: A STUDY BASED ON A RANDOMIZED CONTROLLED TRIAL (NORD-STAR)
Lend K; Wolbink G; Rispens T; Padyukov L; Frazzei G; Christiaans J; Lampa J; Hetland ML; Heiberg MS; Nordstroem D; Nurmohamed M; Rudin A; Ostergaard M; Haavardsholm EA; Horslev-Petersen K; Uhlig T; Gudbjornsson B; Grondal G; Twisk JWR; Van Vollenhoven RF
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2024;83:1670-1671
CIRCULATING ADIPOKINES AND RESPONSE TO TREATMENT IN EARLY RHEUMATOID ARTHRITIS-DATA FROM THE RANDOMIZED NORD-STARTRIAL
Vasileiadis GK; Zhang Y; Fatima T; Van Vollenhoven RF; Lampa J; Gudbjornsson B; Nordstrom D; Grondal G; Horslev-Petersen K; Lend K; Heiberg MS; Hetland ML; Nurmohamed M; Uhlig T; Sokka-Isler T; Rudin A; Maglio C
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:4225-4227
Glucocorticoid Treatment in Early Rheumatoid Arthritis Is Associated with Increased Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Levels: A Post-hoc Analysis of a Randomized Controlled Trial (NORD-STAR)
Lend K; Twisk JWR; Kumar N; Lampa J; Rudin A; Hetland M; Uhlig T; Nordstrom D; Ostergaard M; Heiberg MS; Haavardsholm EA; Gudbjornsson B; Sokka-Isler T; Grondal GM; Horslev-Petersen K; Nurmohamed M; van Vollenhoven R; Frostegard J
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:2606-2609
Certolizumab-pegol, Abatacept, Tocilizumab or Active Conventional Therapy in Early Rheumatoid Arthritis: 48 Week Patient-reported Outcomes of the NORD-STAR Trial
Lampa J; Nordstrom D; van Vollenhoven R; Hetland M; Haavardsholm EA; Ostergaard M; Rudin A; Heiberg MS; Nurmohamed M; Gudbjornsson B; Lend K; Horslev-Petersen K; Sokka-Isler T; Grondal GM; Krabbe S; Lindqvist J; Ekwall A-KH; Glinatsi D; Kapetanovic M; Gentline C; Aga A-B; Relas H; Lorenzen T; Cagnotto G; Back J; Hendricks O; Dijkshoorn B; Oberg K; Ljosa M-KA; Brodin E; Lindegaard HM; Soderbergh A; Rizk M; Kastbom A; Larsson P; Uhrenholt L; Just S; Stevens DJ; Laurberg TB; Bakland G; Olsen I; Sexton J; Uhlig T
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:752-754
Targeting NET Formation in Early RA Patients; A Spin-off Study from the NORD-STAR
Dijkshoorn B; Wang T; Grondal GM; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm E; Hetland ML; Heiberg MS; Ostergaard M; Horslev-Petersen K; Lampa J; van Vollenhoven R; Lood C; Nurmohamed M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:790-791
Obesity Is a Risk Factor for Poor Response to Treatment in Early Rheumatoid Arthritis - a NORD-STAR Spin-Off Study
Dubovyk V; Grondal GM; Gudbjornsson B; Haavardsholm EA; Heiberg MS; Hetland M; Horslev-Petersen K; Kapetanovic M; Kastbom A; Lampa J; Lend K; Nordstrom D; Nurmohamed M; Rizk M; Soderbergh A; Uhlig T; Ostergaard M; van Vollenhoven R; Rudin A; Maglio C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:407-408
OBESITY IS A RISK FACTOR FOR POOR RESPONSE TO TREATMENT IN EARLY RHEUMATOID ARTHRITIS A NORD-STAR SPIN-OFF STUDY
Dubovyk V; Grondal G; Gudbjornsson B; Haavardsholm EA; Heiberg M; Hetland ML; Horslev-Petersen K; Kapetanovic MC; Kastbom A; Lampa J; Lend K; Nordstrom D; Nurmohamed M; Rizk M; Soderbergh A; Uhlig T; Ostergaard M; Van Vollenhoven R; Rudin A; Maglio C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:591-592
TARGETING NET FORMATION IN EARLY RA PATIENTS; A SPIN-OFF STUDY FROM THE NORD-STAR
Dijkshoorn B; Wang T; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm EA; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; Van Vollenhoven R; Sokka-Isler T; Lood C; Nurmohamed M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:3183-3185
Profound Anticoagulant Effects of Initial Antirheumatic Treatments in Early Rheumatoid Arthritis Patients; A NORD-STAR Spin-off Study
Dijkshoorn B; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm E; Grondal GM; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; van Vollenhoven R; Antovic A; Nurmohamed M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:38-40
CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL
Ostergaard M; Van Vollenhoven R; Rudin A; Hetland ML; Heiberg M; Nordstrom D; Nurmohamed M; Gudbjornsson B; Ornbjerg LM; Boyesen P; Olsen I; Lend K; Horslev-Petersen K; Uhlig T; Sokka-Isler T; Grondal G; Krabbe S; Lindqvist J; Gjertsson I; Glinatsi D; Kapetanovic MC; Aga AB; Faustini F; Parmanne P; Lorenzen T; Cagnotto G; Back J; Hendricks O; Vedder D; Rannio T; Grenholm E; Lindegaard HM; Ljosa MKA; Brodin E; Soderbergh A; Rizk M; Hermansson E; Uhrenholt L; Larsson P; Just SA; Bakland G; Stevens D; Laurberg TB; Haavardsholm EA; Lampa J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:515
PLASMA CALPROTECTIN WAS ASSESSED IN MULTIPLE BIOLOGICAL TREATMENT STRATEGIES FOR EARLY RHEUMATOID ARTHRITIS
Stevens D; Heiberg M; Kazemi A; Van Vollenhoven R; Lampa J; Rudin A; Lend K; Hetland ML; Ostergaard M; Nurmohamed M; Horslev-Petersen K; Nordstrom D; Gudbjornsson B; Uhlig T; Haavardsholm EA; Hammer HB
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:40-41
PROFOUND ANTICOAGULANT EFFECTS OF INITIAL ANTIRHEUMATIC TREATMENTS IN EARLY RHEUMATOID ARTHRITIS PATIENTS: A NORD-STAR SPIN-OFF STUDY
Dijkshoorn B; Antovic A; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm EA; Grondal G; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; Van Vollenhoven R; Nurmohamed M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:1701-1705
An Investigator-initiated Multicenter Randomized Study in Early Rheumatoid Arthritis of Active Conventional Therapy versus Three Biological Treatments: 48 Week Clinical and Radiographic Results of the NORD-STAR Trial
Ostergaard M; van Vollenhoven R; Rudin A; Hetland M; Heiberg MS; Nordstrom D; Nurmohamed M; Gudbjornsson B; Ornbjerg L; Boyesen P; Olsen I; Lend K; Horslev-Petersen K; Uhlig T; Sokka-Isler T; Grondal G; Krabbe S; Lindqvist J; Gjertsson I; Glinatsi D; Kapetanovic M; Aga A-B; Faustini F; Parmanne P; Lorenzen T; Giovanni C; Back J; Hendricks O; Vedder D; Rannio T; Grenholm E; Ljosa MK; Brodin E; Lindegaard HM; Soderbergh A; Rizk M; Hermansson E; Larsson P; Uhrenholt L; Just SA; Stevens DJ; Laurberg TB; Bakland G; Haavardsholm E; Lampa J
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:2565-2568
Sex Differences in Treatment Response to Three Different Biological Treatments and Corticosteroids in Patients with Early Rheumatoid Arthritis
Lend K; Van Vollenhoven RF; Lampa J; Hetland M; Haavardsholm E; Nordstrom D; Nurmohamed M; Gudbjornsson B; Rudin A; Ostergaard M; Uhlig T; Grondal G; Horslev-Petersen K; Heiberg MS; Sokka-Isler T; Twisk J; Van der Horst-Bruinsma I
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:13-14
A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL
Hetland ML; Haavardsholm EA; Rudin A; Nordstrom D; Nurmohamed M; Gudbjornsson B; Lampa J; Horslev-Petersen K; Uhlig T; Grondal G; Ostergaard M; Heiberg M; Twisk J; Krabbe S; Lend K; Olsen I; Lindqvist J; Ekwall AKH; Gron KL; Kapetanovic C; Faustini F; Tuompo R; Lorenzen T; Cagnotto G; Baecklund E; Hendricks O; Vedder D; Sokka-Isler T; Husmark T; Ljosa MKA; Brodin E; Ellingsen T; Soderbergh A; Rizk M; Reckner A; Larsson P; Uhrenholt L; Just SA; Stevens D; Laurberg TB; Bakland G; Van Vollenhoven R
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71
A Multicenter Randomized Study in Early Rheumatoid Arthritis to Compare Active Conventional Therapy versus Three Biological Treatments: 24 Week Efficacy and Safety Results of the NORD-STAR Trial
Hetland ML; Haavardsholm EA; Rudin A; Nordstrom D; Nurmohamed M; Gudbjornsson B; Lampa J; Horslev-Petersen K; Uhlig T; Grondal G; Ostergaard M; Heiberg M; Twisk J; Lend K; Krabbe S; Lindqvist J; Ekwall A-K; Gron KL; Kapetanovic M; Faustini F; Tuompo R; Lorenzen T; Cagnotto G; Baecklund E; Hendricks O; Vedder D; Sokka-isler T; Husmark T; Ljosa M-KA; Brodin E; Ellingsen T; Soderbergh A; Rizk M; Reckner A; Uhrenholt L; Larsson P; Just S; Stevens D; Laurberg T; Bakland G; Olsen IC; van Vollenhoven R
Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 2013;525:327-350
Finding Ciliary Genes: A Computational Approach
Henriksson J; Piasecki BP; Lend K; Burglin TR; Swoboda P
Visa fler

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI